Take control of your IBD trials
Inflammatory Bowel Disease (IBD) trials are complex. From inconsistent reads to lengthy timelines and high patient demands, Clario helps you overcome the biggest challenges with proven tools, global expertise, and AI-enhanced precision.
Whether you are running Ulcerative Colitis (UC) or Crohn’s Disease studies, our end-to-end imaging, eCOA, and integrated data solutions streamline execution from Phase I through III – so you stay on track and ahead of schedule.
Trusted by sponsors to deliver smarter, faster IBD trials
Over 300 worldwide IBD trial successes showcase the advantage of partnering with seasoned experts. Gain confidence from early proof-of-concept through pivotal Phase III with reliable, regulator-ready data, thanks to leading gastrointestinal (GI) reviewers and AI-powered tools that minimize variability.
Deliver consistent, defensible Mayo scores with confidence
IBD trials depend on reliable Mayo scores – but reader variability can ruin consistency. Minimize variability and maximize reliability in your IBD trials. Clario’s expert-led, standardized reviews ensure consistent data, streamlined execution, and stronger submissions to regulators.
- AI-assisted segment highlighting to reduce subjectivity
- Real-time scoring tools that guide, not replace, human reviewers
- Audit trails for every read and re-read
Clario’s Clinical Advisory Board
Guiding clinical innovation with scientific leadership.
Accelerate your UC trials with AI-enhanced endoscopy reviews
Clario empowers your trial with AI-enhanced endoscopy reviews that are precise, streamlined and boost confidence in your data – without sacrificing expert oversight.
- Consistent scoring, less variability: AI highlights key colonoscopy segments to support accurate, reproducible reads
- High-quality data: Clear images and smart analytics lead to more confident decisions around treatment efficacy
- Expert-led, AI-assisted: Our human-in-the-loop model ensures clinical accuracy while enhancing speed and efficiency
The girSYNC app works seamlessly with Clario’s platform to align imaging, eCOA, and Mayo scoring – streamlining your entire IBD workflow.
Faster, smarter endoscopy review – anytime, anywhere
Cut delays, improve scoring consistency, and stay trial-ready – no matter where your reviewers are.
The GI Reviewers sync (girSYNC) app integrates answers to the most common challenges facing clinical trial management teams while optimizing the day-to-day experience
How it helps:
- Faster decisions with real-time reader availability and instant alerts for urgent cases
- Boost consistency using AI to spotlight key segments for scoring
- Improve oversight with real-time feedback and annotations
- Stay compliant with 21 CFR Part 11 and GDPR standards
- Track everything via secure cloud access and full audit trails
Why sponsors choose Clario for IBD trials
Proven, powerful solutions built for your success.
- Accelerate progress with experience from 300+ global IBD trials
- Confidently scale across all phases with a team that has done it before
- Boost accuracy with AI-enhanced assessments led by expert GI reviewers
- Minimize delays and risk through streamlined, easy-to-access workflows
- Stay audit-ready with solutions aligned to regulatory expectations from the start
Experience a smarter approach to IBD trials
Join leading sponsors who rely on Clario to strengthen data quality, minimize delays, and advance their IBD research with confidence.
Fill out our form and request a live demo to get started.